Candel Therapeutics, Inc. (CADL)
Candel Therapeutics (CADL) social buzz surges with a 290% increase in social dominance, driven by anticipation of clinical trial results and PDUFA dates. The company's Galaxy Score™ also hit a 52-week high, indicating strong current interest.
About Candel Therapeutics, Inc.
Candel Therapeutics, Inc. is a biotechnology company focused on developing viral immunotherapies.
Candel Therapeutics, Inc. uses the ticker $CADL for trading. Listed in the Stocks category.
Insights
- Candel Therapeutics, Inc. (CADL) social dominance hit [------] which is 222% higher than it's daily average.
- Candel Therapeutics, Inc. (CADL) social dominance is up 791.67% from the previous month.
- Candel Therapeutics, Inc. (CADL) creators is up 38.74% from the previous week.
- Candel Therapeutics, Inc. (CADL) engagements is up 87.66% from the previous week.
- Candel Therapeutics, Inc. (CADL) mentions is up 36.65% from the previous week.
- Candel Therapeutics, Inc. (CADL) posts created is up 200% from the previous week.
- Candel Therapeutics, Inc. Galaxy Score™ hit a 52-Week high of [--] for the hour
Price: $5.60
Price 24-Hour Time-Series Raw Data
The price action is likely driven by anticipation of positive news from upcoming clinical trial results and PDUFA dates, as indicated by social posts mentioning bounces and potential price increases.
24-Hour: -0.88% 7-Day: -4.58% 30-Day: -12.03%
1-Year High: $7 on 2025-07-25
1-Year Low: $4.40 on 2025-11-19
AltRank: [---]
AltRank 24-Hour Time-Series Raw Data
Candel Therapeutics, Inc. (CADL) is currently AltRank #691 based on combined combined social and market metrics
Daily Average: [-----]
[--] Week: [-----] [----]
1-Year High: [-----] on 2026-02-09
1-Year Low: [---] on 2026-01-24
Galaxy Score: [-----]
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [--]
[--] Week: [--] [---]
[--] Month: [--] +18
[--] Months: [--] [---]
[--] Year: [--] [---]
1-Year High: [--] on 2026-02-02
1-Year Low: [--] on 2026-02-05
Engagements: [-----] (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [-----]
[--] Week: [------] +88%
[--] Month: [-------] -11%
[--] Months: [-------] -44%
[--] Year: [---------] -62%
1-Year High: [------] on 2025-07-09
1-Year Low: [--] on 2025-04-19
Engagements by network (24h): News: [--] Reddit: [--] X: [-----] YouTube: [--]
Mentions: [--] (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [--]
[--] Week: [---] +37%
1-Year High: [---] on 2025-06-29
1-Year Low: [--] on 2025-11-09
Mentions by network (24h): News: [--] Reddit: [--] X: [--] YouTube: [--]
Creators: [--] (24h)
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning Candel Therapeutics, Inc. (CADL) in the last [--] hours which is down 70% from [---] in the previous [--] hours
Daily Average: [--]
[--] Week: [---] +39%
1-Year High: [---] on 2025-06-29
1-Year Low: [--] on 2025-11-09
The most influential creators that mention Candel Therapeutics, Inc. in the last [--] hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @BiopharmIQ | [--] | [------] | [--] | [-----] |
| @CandelTx | [--] | [---] | [--] | [---] |
| @TradesProfits | [--] | [---] | [--] | [--] |
| @_le_Lounge | [--] | [-----] | [--] | [--] |
| @BioTechHealthX | [--] | [---] | [--] | [--] |
| @Tompson98315 | [--] | [--] | [--] | [--] |
| @proactive247 | [--] | [------] | [--] | [--] |
| @NJenyns898 | [--] | [--] | [--] | [--] |
Sentiment: 67%
Sentiment 24-Hour Time-Series Raw Data
Current Value: 67%
Daily Average: 85%
[--] Week: 50% -50%
[--] Month: 40% -31%
[--] Months: 40% -45%
[--] Year: 40% -36%
1-Year High: 100% on 2025-02-18
1-Year Low: 9% on 2025-11-16
Most Supportive Themes:
- Biotech Stock Catalyst Watchlist: (67%) Focuses on upcoming clinical trial readouts for various biotechnology companies.
- Stock Bounce Potential: (33%) Highlights potential stock price increases based on market movements and specific company news.
Most Critical Themes:
Social Dominance: 0.0032%
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.0032%
Daily Average: 0.00665%
[--] Week: 0.00311% +0.00141%
[--] Month: 0.021% +0.019%
[--] Months: 0.021% +0.01%
[--] Year: 0.021% +0.0047%
1-Year High: 0.036% on 2025-06-29
1-Year Low: 0.0004% on 2025-11-09
Market Dominance: 0.00035052684186712136%
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00035052684186712136%
Daily Average: 0%
1-Year High: 0.015% on 2026-02-06
1-Year Low: 0.00035% on 2026-02-17
Market Cap: $309,077,446
Market Cap 24-Hour Time-Series Raw Data
Current Value: $309,077,446
Daily Average: $325,745,181
[--] Week: $310,175,412 -5.20%
[--] Month: $310,175,412 -12%
1-Year High: $351,349,139 on 2026-01-16
1-Year Low: $290,412,023 on 2026-02-05
Top Candel Therapeutics, Inc. Social Posts
Top posts by engagements in the last [--] hours
Showing a maximum of [--] top social posts without a LunarCrush subscription.
"Biotech Stock Catalyst Watchlist Ph2 & Ph3 readouts in Q1 [----] 📈 $BIVI Phase [--] $MDNAF Phase 2b $DBVT Phase [--] $GOSS Phase [--] $MLTX Phase [--] $BFRI Phase [--] $BCDA Phase [--] $KPTI Phase [--] $IOVA Phase [--] $XENE Phase [--] $AGIO Phase 2b $AVBP Phase [--] $ATAI Phase [--] $MLYS Phase [--] $TARA Phase [--] $CADL Phase 2a $ANRO Phase [--] $IMMP Phase [--] $PEPG Phase [--] $TBPH Phase [--] $CLDX Phase [--] $NVCR Phase [--] $VRDN Phase [--] $CMPX Phase 2/3 $IDYA Phase 2/3 $VXRT Phase 2b $OCUL Phase [--] $LSTA Phase 2b $PCSA Phase [--] $OCGN Phase [--] $APGE Phase [--] $CMPS Phase [--] $MBRX Phase [--] $KOD Phase [--] $ALZN Phase [--] $HELP Phase [--] $PVLA Phase [--] $INSM"
X Link @BiopharmIQ 2026-02-15T19:38Z 28.9K followers, 15K engagements
"This #CancerPreventionMonth we honor the power of research education and early action in fighting cancer. Our off-the-shelf multimodal immunotherapies harness the immune system to fight cancer. Together we're working to bring new treatment options to those who need them"
X Link @CandelTx 2026-02-13T15:00Z [---] followers, [---] engagements
"Biotech Stock Catalyst Watchlist Ph2 & Ph3 readouts in Q1 [----] 📈 $MDNAF Phase 2b $GOSS Phase [--] $BFRI Phase [--] $MLTX Phase [--] $BFRI Phase [--] $BCDA Phase [--] $KPTI Phase [--] $IOVA Phase [--] $XENE Phase [--] $AGIO Phase 2b $AVBP Phase [--] $ATAI Phase [--] $MLYS Phase [--] $TARA Phase [--] $CADL Phase 2a $ANRO Phase [--] $IMMP Phase [--] $PEPG Phase [--] $TBPH Phase [--] $CLDX Phase [--] $NVCR Phase [--] $VRDN Phase [--] $CMPX Phase 2/3 $ZBIO Phase [--] $IDYA Phase 2/3 $VXRT Phase 2b $OCUL Phase [--] $LSTA Phase 2b $PCSA Phase [--] $OCGN Phase [--] $APGE Phase [--] $CMPS Phase [--] $MBRX Phase [--] $KOD Phase [--] $NKTR Phase 2b $ALZN Phase [--] $HELP Phase [--] $PVLA"
X Link @BiopharmIQ 2026-02-08T18:59Z 28.9K followers, 23.9K engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing